79 results about "Basement membrane" patented technology

The invention provides a micromolecular recombinant XVII type collagen as well as a preparation method and application thereof, and relates to the technical field of protein engineering. The novel recombinant human XVII type collagen is obtained by optimizing and screening a plurality of spiral region sequences such as a collagen structural domain, a C-terminal region and a middle region of the human XVII type collagen. The amino acid composition of the recombinant XVII type collagen is consistent with that of a natural collagen alpha1 chain, immunological rejection is not generated when the recombinant XVII type collagen is applied to a human body, the recombinant XVII type collagen can be widely applied to surgical medical treatment and medical beauty industries, the molecular weight of the collagen is small, efficient secretion soluble expression in eukaryotic host cells such as pichia pastoris can be achieved, and the recombinant XVII type collagen has a good application prospect. And industrial large-scale production is carried out. According to the present invention, the verification results show that the micromolecular recombinant XVII type collagen further has basement membrane anti-aging activity, wherein the basement membrane anti-aging activity specifically comprises the improvement of the expression levels of the IV type collagen, the VII type collagen and the XVII type collagen;

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and / or other pulmonary diseases or disorders.

The invention provides a gel dressing and a preparation method thereof, and belongs to the technical field of medical materials.The gel dressing comprises a basement membrane which is a PVA membrane; the gel layer is arranged on the surface of the basement membrane, and the gel layer is prepared from recombinant collagen, exosome, sodium hyaluronate, sodium carboxymethyl cellulose, chitosan and water; the microneedles are evenly arranged on the side, away from the basement membrane, of the gel layer, the microneedles are made of polylactic acid-hydroxy acid copolymer, and the needle tips of the microneedles are loaded with recombinant collagen and exosomes. A skin channel is opened through the microneedle array, the permeation efficiency of recombinant collagen and exosome is improved by multiple times, a large number of active ingredients can quickly reach the deep layer of the skin, and the skin repairing effect is remarkably enhanced.

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, those within the respiratory tract, particularly the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The systems may be used to treat pathogens, such as bacteria and viruses, particularly coronaviruses.

The invention provides a polypeptide compound and application thereof, and belongs to the technical field of medical or dressing preparations. According to the invention, three specific polypeptides are synergistically proportioned to obtain the polypeptide compound, and the polypeptide compound has the effect of repairing a skin basement membrane in a targeted manner. The polypeptide compound has the advantages of being small in molecular weight, high in safety, low in allergy risk and high in permeability, and has excellent repairing and anti-aging functions. Experiments prove that the polypeptide compound provided by the invention, as an active peptide raw material, can remarkably promote the production of endogenous collagen IV, VII and XVII of skin, is also beneficial to repairing skin extracellular matrix, resisting DNA damage, improving skin cycle protein, inhibiting release of inflammatory factors and the like, can effectively repair a basement membrane, and has a wide application prospect.

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and / or other pulmonary diseases or disorders.

The invention relates to a fused exosome-like vesicle based on stem cell exosomes and application thereof, and the fused exosome-like vesicle is prepared by a method comprising the following steps: mixing stem cell exosomes and aloe exosome-like vesicles under an ultrasonic condition, and incubating to obtain the fused exosome-like vesicle. The fused exosome-like vesicle can effectively promote percutaneous penetration of stem cell exosome, and can effectively improve cell damage caused by ultraviolet rays, regenerate and repair skin damage barriers such as basilar membranes and the like, resist inflammation and oxidation, effectively remove melanin, and improve the skin quality. The composition has good repair potentials for chloasma and skin damage, aging and melanin deposition related to chloasma. Sufficient data support and technical support are provided for research and development of stem cell exosome innovative drugs, and clinical application of the stem cell exosome innovative drugs is accelerated.

The growth factor profile, connective tissue matrix constituents, and immunoprivileged status of urodele extracellular matrix (ECM) and accompanying cutaneous tissue, plus the presence of antimicrobial peptides there, render urodele-derived tissue an ideal source for biological scaffolds for xenotransplantation. In particular, a biological scaffold biomaterial can be obtained by a process that entails (A) obtaining a tissue sample from a urodele, where the tissue comprises ECM, inclusive of the basement membrane, and (B) subjecting the tissue sample to a decellularization process that maintains the structural and functional integrity of the extracellular matrix, by virtue of retaining its fibrous and on-fibrous proteins, glycoaminoglycans (GAGs) and proteoglycans, while removing sufficient cellular components of the sample to reduce or eliminate antigenicity and immunogenicity for xenograft purposes. The resultant urodele-derived biomaterial can be used to enhance restoration of skin homeostasis, to reduce the severity, durations and associated damage caused by post-surgical inflammation, and to promote progression of natural healing and regeneration processes. In addition, the biomaterial promotes the formation of remodeled tissue that is comparable in quality, function, and compliance to undamaged human tissue.

The invention provides a binding protein specifically bound with a glomerular basement membrane, a preparation method and application, and relates to the technical field of biology. The binding protein contains a heavy chain variable region and a light chain variable region, wherein a complementary determining region of the heavy chain variable region comprises amino acid sequences consistent with VH-CDR1, VH-CDR2 and VH-CDR3 of the heavy chain variable region shown as SEQ ID NO.1; the complementarity determining region of the light chain variable region comprises amino acid sequences which are consistent with the amino acid sequences of VL-CDR1, VL-CDR2 and VL-CDR3 of the light chain variable region as shown in SEQ ID NO.2. The binding protein has good specific binding capacity with a glomerular basement membrane antigen, and can be used for identification of an anti-glomerular basement membrane antibody or the glomerular basement membrane antigen, and diagnosis and detection of anti-glomerular basement membrane antibody positive diseases and / or vasculitis or auxiliary diagnosis and detection of the anti-glomerular basement membrane antibody positive diseases and / or vasculitis.

The invention discloses a recombinant IV-type collagen as well as a preparation method and application thereof. The recombinant IV-type collagen is prepared by repeating a sequence as shown in SEQ ID NO.1 for n times (1lt; the recombinant IV-type collagen can effectively promote skin basilar membrane cells to express IV, VII and XVII-type collagen, can repair and reinforce skin barriers, so that the compactness and elasticity of skin are improved, basilar membrane repair is facilitated, the recombinant IV-type collagen can be effectively used for preparing anti-aging products, and the anti-aging effect is good. Wide application prospects are realized in the fields of medical instruments, beauty and skin care and the like. The invention also discloses a method for expressing the recombinant IV type collagen by recombinant escherichia coli, and the method provided by the invention has the advantages of high protein yield, high purity and high yield, and lays a foundation for industrial large-scale production.

The invention relates to the field of new biological materials, in particular to a high-packaging-dose antibacterial slow-release biological patch obtained by packaging at least two antibiotics with an acellular matrix material. The acellular matrix material is derived from any two of small intestinal submucosa, peritoneum, dermis, bladder basement membrane and pericardium; the antibiotics comprise hydrophobic antibiotics and hydrophilic antibiotics, and the hydrophobic antibiotics are selected from one or more of Beta-lactam antibiotics, rifamycin and macrolide antibiotics; the hydrophilic antibiotics are tetracycline antibiotics. The coating-free drug-loaded sustained-release system based on a lamination process kills bacteria in a short period, prevents colonization and reproduction of bacteria in a wound / patch, realizes synergistic and continuous release of antibiotics along with a wound healing process, guides tissue regeneration and synchronously realizes degradation, is applied to a high-incidence infection period of a surgical operation, reduces adhesion, and has a good application prospect. The abdominal wall strength is enhanced, and the growth of wound granulation tissues is promoted.

The invention belongs to the technical field of medical instruments, and particularly relates to a medical multifunctional operation pasting film which is characterized in that the medical multifunctional operation pasting film comprises a sterile basement film, an anatomical structure body surface projection layer is arranged on the surface of the sterile basement film, and the anatomical structure body surface projection layer comprises a nerve and blood vessel identification area, a tissue level identification area and an operation path guiding area; an anti-curling adhesive tape is arranged at the edge of the sterile base film, and release paper is fixedly connected to the back surface of the sterile base film. In the anatomical structure body surface projection layer, the nerve and blood vessel identification area is printed through vegetable dye, blood vessels and nerves are clearly distinguished through red fluorescent dye and blue fluorescent dye under ultraviolet light, and positioning errors caused by traditional hand drawing are avoided; protruding texture of the tissue level identification area assists a surgeon in judging the dissection depth through touch feedback, scale marks and an erasable coating of the operation path guiding area support accurate measurement and personalized marking in the operation, and the risk of important tissue damage is reduced.

To provide interventional procedures which are easy to control, match pathophysiologic aberrancies, allow treatment of large surface areas at appropriate depths, and can limit amounts of inflammatory response and remodeling.SOLUTION: Systems and methods are provided for treating pulmonary tissues via delivery of energy to target tissue using a pulmonary tissue modification system (100) such as an energy delivery catheter (102) system. Example pulmonary tissues include the epithelium (goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, and / or nerves. The system may be used to treat a variety of pulmonary diseases or pulmonary disorders such as COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), and / or acute bronchitis.SELECTED DRAWING: Figure 5

The invention provides a basement membrane sampling method based on glomerular capillary branch characteristics, and relates to the technical field of image recognition, and the method comprises the steps: employing the center and radius of a glomerular region, carrying out the analysis of the mesangial crossing condition of a basement membrane, obtaining a mesangial crossing result, carrying out the region division and sampling window size calculation, and carrying out the calculation of the size of a sampling window. Obtaining a plurality of sectors and corresponding window areas; random sampling is carried out in the sectors to obtain candidate center points; analyzing the candidate center point based on the window area, if the sampling is not qualified, performing failure retry and annealing strategy to adjust the window, and resampling; otherwise, obtaining a qualified window; and combining all qualified windows to obtain a basement membrane sampling result, and completing the basement membrane sampling based on the glomerular capillary branch characteristics. According to the method, the problem of how to perform balanced, low-deviation, reproducible and efficient sampling and labeling on the glomerular basement membrane under the anatomical priori constraint in the light microscope glomerular pathological image is solved.

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located on top of and within the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high levels of laminin-5, a cell adhesion bio-active factor shown to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

The invention discloses a construction method of a COL4A5-K229X point mutation X-linked Alport syndrome mouse model. The construction method comprises the following steps: aiming at c.685Agt of a No.12 exon of a mouse COL4A5 gene; carrying out T point mutation, and designing and preparing Cas9 mRNA, gRNA and a donor vector; the components are mixed and then microinjected into fertilized eggs of a C57BL / 6J mouse to obtain an F0-generation mouse; identifying the genotype through PCR (Polymerase Chain Reaction) amplification and Sanger sequencing, and screening positive mice; mating the positive F0-generation mice with the wild-type mice, and breeding F1-generation and subsequent generations; the phenotype of the model is further verified through qPCR, biochemical analysis, light microscopic examination, transmission electron microscope and immunofluorescence. The model constructed by the invention shows hematuria, proteinuria, azemia, podocyte loss and irregular thickening and layering of glomerular basement membrane, is consistent with phenotypes of human XLAS patients, and provides an animal model tool for analyzing pathogenesis and developing treatment strategies.

The application discloses a kind of tissue regeneration fillers and preparation method and application thereof, belong to the field of biomedical materials and medical cosmetology technical field. Including the following mass fraction components: mixed microparticle 1.0~5.0 parts;Mixed microparticle includes acellular matrix microparticle and basement membrane microparticle, and the mass ratio of acellular matrix microparticle and basement membrane microparticle is 10‑1:1.The application extracts and compounding two kinds of microparticles respectively, combines gel matrix and dispersion liquid processing, retains the scaffold function of acellular matrix, supplements basement membrane specific active ingredient, realizes instant support and long-acting regeneration synergy;Filler has excellent injectability and biocompatibility, can accurately repair basement membrane structure degradation, promote cell directional migration and tissue functional regeneration, and is widely used in facial rejuvenation, wound repair and soft tissue regeneration.

The utility model discloses a microneedle application patch structure which comprises a flexible basement membrane, an active functional layer and a plurality of microneedles. The flexible substrate film is a flexible film; the active functional layer is combined on a first surface of the flexible substrate film; each microneedle comprises a needle bottom, a needle body and a needle tip which are integrally formed; the needle bottom is combined with the first surface of the flexible base film, the active functional layer covers the needle bottom, and the needle body and the needle tip protrude out of the surface of the active functional layer; the microneedle is of a solid structure made of a soluble high-molecular polymer. When the microneedle application sheet is used, the active functional layer and the microneedle face and are tightly attached to the surface of the skin, the microneedle can pierce the cuticle and the epidermal layer of the skin of a user to form a micropore transmission channel, and effective components permeate into the deep layer of the skin.

The present invention provides a recombinant type IV collagen composition for repairing basement membrane and soothing and reducing redness. The inventors found that the recombinant type IV collagen described in the specification of this patent inhibits the phosphorylation of VE-cadherin protein by mediating the PKCα / PYK2 / Src signaling pathway, protects the tight junctions between endothelial cells, prevents the leakage of blood components, and reduces vascular permeability; it can also improve the dissociation of the VE-cadherin complex caused by oxidative stress and maintain the homeostasis of the endothelial barrier; therefore, it has good effects of repairing the basement membrane barrier and soothing and reducing redness. The inventors also first discovered that the repair peptide (GAAGLPGPK) has the effects of repairing the basement membrane barrier, soothing and reducing redness, and the combination of a certain proportion of the recombinant type IV collagen and the repair peptide shows synergistic effects in repairing the basement barrier and soothing and reducing redness.

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and / or other pulmonary diseases or disorders.

The present disclosure relates to RNAi agents able to inhibit Complement Factor B (CFB) gene expression. Also disclosed are pharmaceutical compositions that include CFB RNAi agents and methods of use thereof. The CFB RNAi agents disclosed herein may be conjugated to targeting ligands, including ligands that comprise N-acetyl-galactosamine, to facilitate the in vivo delivery to hepatocyte cells. The RNAi agents can be used in methods of treatment of diseases, disorders, or symptoms mediated in part by CFB gene expression, including IgA nephropathy (IgAN), C3 glomerulopathy (C3G), immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN), lupus nephritis (LN), Anti-Glomerular Basement Membrane disease (anti-GBM), ischemia reperfusion injury and T-cell mediated rejection (TCMR) in kidney transplantation, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, age-related macular degeneration (AMD), including early and / or intermediate AMD, geographic atrophy (GA), glaucoma, Doyne honeycomb retinal dystrophy, paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), pre-eclampsia, rheumatoid arthritis (RA), and / or other complement-mediated diseases.

The present invention provides a composite vascular stent coating for regulating the growth activity of endothelial cells and a preparation method thereof; the composite vascular stent coating of the present invention uses silk nanofiber membranes as the inner and outer layers of the composite vascular stent coating, and adopts weaving technology to weave a seamless polyester tubular fabric as the core layer on the basis of the inner layer of the composite vascular stent coating; the composite vascular stent coating has a microstructure and matrix-like components that imitate the basement membrane of natural blood vessels, which is beneficial to the mechanical engagement between the outer surface of the coating and the inner side of the diseased blood vessel, stabilizes blood flow, avoids turbulence formation, and more significantly improves the adhesion, spreading, growth and proliferation ability of endothelial cells on its inner surface, quickly forms a new endothelial layer, inhibits the occurrence of thrombosis and inflammation, maintains long-term patency of the lumen, and has good application value.

The invention relates to the technical field of biology, in particular to a method for modular assembly of artery blood vessel type organs and construction of tissue microcirculation of the artery blood vessel type organs. The method comprises the following steps: inducing human pluripotent stem cells to differentiate through a mesoderm stage to form an arterial specific vascular organoid module (AVO), and then carrying out modular assembly on the AVO in vivo or in vitro so as to quickly reconstruct a tissue microcirculation network with arterial characteristics. The obtained artery blood vessel organoid is uniform in form, the diameter of the artery blood vessel organoid is intensively distributed at about 200 microns, SOX17 and CXCR4 artery endothelial markers are expressed at the same time, and the artery blood vessel organoid has polarity and a complete basilar membrane. Transplanting experiments show that the organ can be integrated with host blood vessels in a short time, and ischemic tissue blood perfusion is recovered. The defects that existing organoid is irregular, difficult to splice, delayed in perfusion and the like are overcome, and a new strategy is provided for revascularization and acute ischemic disease repair.

The growth factor profile, connective tissue matrix constituents, and immunoprivileged status of urodele extracellular matrix (ECM) and accompanying cutaneous tissue, plus the presence of antimicrobial peptides there, render urodele-derived tissue an ideal source for biological scaffolds for xenotransplantation. In particular, a biological scaffold biomaterial can be obtained by a process that entails (A) obtaining a tissue sample from a urodele, where the tissue comprises ECM, inclusive of the basement membrane, and (B) subjecting the tissue sample to a decellularization process that maintains the structural and functional integrity of the extracellular matrix, by virtue of retaining its fibrous and on-fibrous proteins, glycoaminoglycans (GAGs) and proteoglycans, while removing sufficient cellular components of the sample to reduce or eliminate antigenicity and immunogenicity for xenograft purposes. The resultant urodele-derived biomaterial can be used to enhance restoration of skin homeostasis, to reduce the severity, durations and associated damage caused by post-surgical inflammation, and to promote progression of natural healing and regeneration processes. In addition, the biomaterial promotes the formation of remodeled tissue that is comparable in quality, function, and compliance to undamaged human tissue.

The invention relates to the field of biological materials, in particular to a preparation method of a bioprosthetic valve, the bioprosthetic valve is obtained by wrapping a cross-linked extracellular matrix material with a non-cross-linked biological basement membrane to form a sandwich structure, and the preparation method specifically comprises the following steps: respectively preparing the non-cross-linked biological basement membrane and the cross-linked extracellular matrix material; and the collagen derivative mixed solution with the area concentration of 8-50 [mu] L / cm < 2 > and the activator mixed solution with the area concentration of 1-10 [mu] L / cm < 2 > are combined and laminated. The advantages of good regeneration and repair performance and carrying of rich bioactive factors of the basement membrane are utilized, growth and adhesion of endothelial cells on the surface of the material are promoted, an endothelial structure similar to natural blood vessels is formed, the composite bioprosthetic valve has good anti-calcification performance, adhesion of platelets and blood cells is reduced, and the bioprosthetic valve has good anti-calcification performance. The recovery and reconstruction of the valve function are accelerated; moreover, erythrocyte rupture and dissolution are not easily caused, the damage degree to erythrocytes is low, and the blood coagulation risk is low.

A system and methods are provided for amniotic grafts for encouraging healing of incisions applied to the feet, ankles, and other parts of the body. The amniotic graft comprises a multi-layer matrix and a shape for treating the incisions. The amniotic graft comprises an acellular amniotic membrane or a cellular amniotic membrane. The multi-layer matrix comprises an amnion or chorion layer that enables rapid remodeling of soft-tissue wounds. A spongy layer separates a fibroblast layer and the amnion or chorion layer. The multi-layer matrix includes a compact layer, a basement membrane, and an epithelium. The shape comprises a rectangle having a width and length that are suitable for treating the incision. The amniotic grafts can be sterile packaged with sterile instruments for implanting the grafts to treat soft-tissue wounds. The wound can include surgical incisions, muscle strains, as well as tendon and ligament disruption to various locations of the body.

The present application relates to the field of biomaterials, and particularly relates to a biomimetic biological valve. The biomimetic biological valve is obtained by wrapping a non-crosslinked biological basement membrane around a crosslinked extracellular matrix material to form a sandwich structure. The basement membrane cooperates with the crosslinked extracellular matrix material, fully plays the excellent regenerative repair performance and the characteristics of being rich in bioactive factors of the basement membrane, effectively promotes the growth and adhesion of endothelial cells on the surface of the material, and constructs a tissue structure similar to the natural valve leaflet. The biomimetic biological valve exhibits excellent anti-calcification performance and excellent dynamic mechanical stability and compliance, significantly inhibits the abnormal adhesion of platelets and blood cells, greatly improves the recovery and reconstruction efficiency of the valve function, and can maintain the structural integrity in repeated contraction-expansion cycles, providing an ideal solution for long-term stable application in a physiological environment.

This invention discloses an oral ablation detection method and system, belonging to the field of oral detection technology, including: S1, oral tissue sampling; S2, motion compensation; S3, image reconstruction; S4, lesion analysis; S5, ablation planning; S6, ablation execution. This invention utilizes phase-amplitude joint displacement estimation, extracting depth-direction micro-displacement using phase difference and lateral displacement using amplitude centroid shift. This effectively compensates for non-rigid tissue peristalsis caused by swallowing and tongue movements without relying on external markers or high-frequency frame rates, ensuring that the subsequently reconstructed three-dimensional image and ablation target area localization are not distorted due to motion, thus improving the targeting consistency between detection and treatment. Texture analysis at different scales is applied along the oral mucosal epithelium, basement membrane zone, and lamina propria, and depth-adaptive weights are assigned based on the pathological sensitivity differences of each layer, highlighting the probabilistic response of early cancerous areas.

This invention discloses an engineered extracellular vesicle and its application in the preparation of products for treating autoimmune diseases. The engineered extracellular vesicle is either an IDO1-overexpressing engineered extracellular vesicle (MSC-IDO1-EVs) or a CSF1-overexpressing engineered extracellular vesicle (MSC-CSF1-EVs). The engineered extracellular vesicles provided by this invention exhibit significant immunosuppressive effects, reducing the secretion of inflammatory cytokines. In animal models, they effectively reduce proteinuria levels, significantly reduce blood dsDNA / ANA levels, effectively alleviate kidney damage caused by autoimmune diseases such as renal immune complex deposition, diffuse thickening of the glomerular basement membrane, and mesangial structural disorder, and reduce overall inflammation levels in mice. The therapeutic effect is significantly superior to that of unmodified MSC-EVs. The engineered extracellular vesicles provided by this invention significantly improve the therapeutic effect on autoimmune diseases.

The present invention discloses a basement membrane repair composition and its preparation method and application, comprising hydrolyzed sodium hyaluronate, small molecule sodium chondroitin sulfate and water; wherein, by total mass percentage of raw materials, the hydrolyzed sodium hyaluronate is 1-20%, the small molecule sodium chondroitin sulfate is 0.05-5%, and the balance is water to 100%. The composition can promote skin cells to express AQP3, type I collagen and type III collagen, and promote skin cells to express type IV collagen, type VII collagen and type XVII collagen, etc., the main ECM of the basement membrane, so that the composition has both moisturizing and firming effects.